Table 3.
AA cases (n=1052) n (%) |
AA controls (n=2328) n (%) |
White cases (n=2380) n (%) |
White controls (n=3982) n (%) |
pcontrolsb | |
---|---|---|---|---|---|
Age (y) (M (SD)) | 58.2 (11.5) | 57.9 (13.3) | 59.0 (11.2) | 58.9 (12.8) | <.01 |
No. missing | 0 | 1 | 0 | 0 | |
BMI ≥30 kg/m2 | 563 (54) | 1042 (45) | 504 (21) | 734 (19) | <.01 |
No. missing | 8 | 34 | 22 | 26 | |
College degree | 343 (33) | 821 (35) | 1224 (51) | 2216 (56) | <.01 |
No. missing | 2 | 14 | 1 | 14 | |
Family history of ovarian cancer | 60 (6) | 69 (3) | 120 (5) | 121 (3) | 0.94 |
No. missing | 93 | 127 | 48 | 78 | |
Menarche age <11 years | 107 (10) | 228 (10) | 172 (7) | 257 (6) | <.01 |
No. missing | 9 | 20 | 6 | 12 | |
Duration of oral contraceptive use | |||||
Never used | 396 (38) | 861 (38) | 989 (42) | 1496 (38) | 0.52 |
<5 yearsc | 376 (36) | 757 (33) | 833 (36) | 1258 (32) | |
5+ years | 261 (25) | 659 (29) | 519 (22) | 1182 (30) | |
No. missing | 19 | 51 | 39 | 46 | |
Full-term pregnancies | |||||
None | 197 (19) | 354 (15) | 618 (26) | 802 (20) | <.01 |
1 | 186 (18) | 459 (20) | 342 (14) | 577 (15) | |
2 | 227 (22) | 571 (25) | 716 (30) | 1227 (31) | |
3 | 214 (20) | 417 (18) | 410 (17) | 752 (19) | |
4+ | 225 (21) | 518 (22) | 293 (12) | 614 (15) | |
No. missing | 3 | 9 | 1 | 10 | |
Ever breastfedd,e | 284 (39) | 677 (46) | 775 (47) | 1422 (59) | <.01 |
No. missing | 48 | 28 | 1 | 2 | |
Tubal ligation | 304 (29) | 699 (30) | 353 (15) | 708 (18) | <.01 |
No. missing | 5 | 7 | 5 | 11 | |
Ever used menopausal hormonesf | 207 (27) | 478 (31) | 991 (55) | 1509 (52) | <.01 |
No. missing | 8 | 54 | 7 | 24 |
Table does not include data from SCCS or WHI; these studies were added to the consortium recently, and their risk factor data have not yet been fully harmonized.
Invasive only
Testing for the difference between African American and white controls
Includes participants who used oral contraceptives for <1 year
Among parous women
Not collected by MEC
Among women older than 50